New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years

Blood

Volumn 104, Issue 4, 2004, Pages 1201-1203

  Sodani, Pietro ^b   Gaziev, David ^b   Polchi, Paola ^b   Erer, Buket ^b   Giardini, Claudio ^b   Angelucci, Emanuele ^b   Baronciani, Donatella ^b   Andreani, Marco ^b   Manna, Marisa ^b   Nesci, Sonia ^b   Lucarelli, Barbarella ^b   Clift, Reginald A ^b   Lucarelli, Guido ^a  

^a Mediterranean Institute of Hematology   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; METHOTREXATE; PREDNISOLONE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRIMETHOPRIM;

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DRUG TOLERABILITY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; THALASSEMIA;

EID: 19244366141     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-08-2800     Document Type: Article

References (12)

1. Olivieri NF, Brittenham GM. Iron-chelation therapy and the treatment of thalassemia. Blood. 1977;89:739-761.
2. Davis A, Brown BB, Prokopishyn NL. Yannariello-Brown J. Micro-injection-mediated hematopoietic stem cell gene therapy. Curr Opin Mol Ther. 2000;2:412-419.
3. Roberts L. Current status of allogeneic transplantation for hemoglobinopathies. Br J Haematol. 1997;98:1-7.
4. Li CK, Shing MM, Chik KW, et al. Hematopoietic stem cell transplantation for thalassemia major in Hong Kong: prognostic factors and outcome. Bone Marrow Transplant. 2002;29:101-105.
5. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med. 1990;322:417-421.
6. Lucarelli G, Andreani M, Angelucci E. The cure of thalassemia by bone marrow transplantation. Blood Rev. 2002;16:81-85.
7. Lucarelli G, Clift RA, Galimberti M, et al. Marrow transplantation for patients with thalassemia. Results in class 3 patients. Blood. 1996;87:2082-2088.
8. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons; 1980.
9. Sullivan KM, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250-259.
10. Nash RA, Pepe MS, Storb R, et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood. 1992;80:1838-1845.
11. Andreani M, Manna M, Lucarelli G, et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood. 1996;87:3494-3499.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.